Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

14. November 2012 09:00 ET | Quelle: biOasis Technologies Inc.

biOasis Enters Into a Research & Evaluation Agreement with MedImmune

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Nov. 14, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that it has entered into a research and evaluation agreement with...
24. September 2012 09:00 ET | Quelle: biOasis Technologies Inc.

biOasis Receives Preliminary Histopathology (Tissue Toxicity) Results on Its Herceptin(R) BT2111 Program

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 24, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces today positive results of a preliminary toxicity evaluation of test...
05. September 2012 09:30 ET | Quelle: biOasis Technologies Inc.

biOasis's Herceptin(R)-BT2111 Stops Human Breast Cancer Tumor Growth in Animals

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 5, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that a key animal study in its BT2111 oncology program, showed that...
28. August 2012 19:36 ET | Quelle: biOasis Technologies Inc.

biOasis Technologies Inc.: 2012-2013 Board of Directors Election, Officers Appointment and Option Grant

VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 28, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces its board of directors elected by the shareholders at its Annual General...
19. Juli 2012 18:38 ET | Quelle: biOasis Technologies Inc.

Option Grant-biOasis Technologies Inc.

VANCOUVER, BRITISH COLUMBIA--(Marketwire - July 19, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces that is has granted options to its officers, employees, consultants and...
27. Juni 2012 10:22 ET | Quelle: biOasis Technologies Inc.

Experienced Life Science Executive Joins biOasis Board of Directors

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 27, 2012) - biOasis Technologies Inc. (BTI) (TSX VENTURE:BTI) is pleased to announce that Mr. Gregory Gubitz has joined the Board of...
18. Juni 2012 09:00 ET | Quelle: biOasis Technologies Inc.

biOasis Enters Research & Evaluation Agreement With Abbott

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 18, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that it has entered into an agreement with Abbott, to evaluate...
11. Juni 2012 09:00 ET | Quelle: biOasis Technologies Inc.

biOasis Receives Compelling Data From Texas Tech University On Its Herceptin(R) BT2111 Program

VANCOUVER, BRITISH COLUMBIA--(Marketwire - June 11, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announced today that research underway at Texas Tech University Health Sciences...
31. Mai 2012 19:58 ET | Quelle: biOasis Technologies Inc.

biOasis Announces Grant of Stock Options to IR Providers

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 31, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) announces that subject to regulatory approval it will grant additional options in...
08. Mai 2012 09:00 ET | Quelle: biOasis Technologies Inc.

biOasis Transcend Vector Delivers an Anti-Amyloid Beta (AB) Antibody To The Brain

VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 8, 2012) - biOasis Technologies Inc. (TSX VENTURE:BTI) today announces test results from its Transcend therapeutic development program...

Vorherige Seite